News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Investing.com Nigeria Market update
This article reports on ABVC Biopharma Inc.'s Form 8K filing for August 12. The filing is a standard requirement for publicly traded companies to announce significant events that shareholders should know. The article provides the title of the filing and mentions the company's stock symbol and a slight decrease in its share price.
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides an earnings forecast for ABVC Biopharma Inc (ABVC), focusing on future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a peer comparison from the biotechnology and medical research sector. The forecast sections cover expected EPS, revenue, …
This article provides the current stock news and financial overview for ABVC Biopharma Inc (ABVC). It highlights the company's stock performance, market capitalization, and various financial and analytical tools available on the TradingKey platform. The article also indicates that more news will be coming …
ABVC BioPharma, Inc. (NASDAQ: ABVC) has postponed the distribution of BioKey (Cayman), Inc. ordinary shares, originally set for August 3, 2026, due to pending administrative, regulatory, and tax matters. While the record date and distribution ratio remain unchanged, the ex-dividend date will be reset …
ABVC Biopharma has postponed the planned August 3 distribution of BioKey ordinary shares to address administrative, regulatory, and tax matters. The distribution ratio of 0.169464 BioKey shares per ABVC common share and the record date remain unchanged. ABVC will announce new distribution and ex-dividend …
This article provides a risk assessment for ABVC Biopharma Inc (ABVC), noting its current risk score of 3.01 and ranking within the Biotechnology & Medical Research industry. It details the company's beta value of 0.54, indicating lower volatility compared to the S&P 500, and …
ABVC BioPharma is holding a virtual special shareholder meeting on September 18, 2026, to vote on three key proposals. These include approving a new 2026 Equity Incentive Plan, ratifying equity awards granted after February 16, 2026, and authorizing the issuance of up to 6,638,591 …
This article provides an overview of ABVC Biopharma Inc's (ABVC) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists several merger-related stock splits that occurred on July 24, 2023, each …
This article provides a detailed cash flow statement for ABVC Biopharma Inc (ABVC), encompassing quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and their significance for the company's financial health. …
This article from TradingKey provides a revenue breakdown for ABVC Biopharma Inc (ABVC), detailing its business segments, regional revenue, and profit contribution. However, the data has not been disclosed by the company yet, indicating a lack of publicly available information on these specific financial …
This article provides a technical analysis of ABVC Biopharma Inc (ABVC), noting its current stock price momentum score is 5.98, ranking 29th in its industry. The stock is trading between a resistance level of 1.79 and a support level of 0.60, suggesting suitability for …
The article analyzes the institutional confidence in ABVC Biopharma Inc (ABVC), noting its current institutional shareholding score of 3.00, placing it 192nd in its industry. Institutional ownership stands at 3.41%, an increase of 1.88% quarter-over-quarter. James Simons is identified as the largest institutional shareholder, …
This article provides the comprehensive balance sheet for ABVC Biopharma Inc (ABVC), presenting both quarterly and annual financial data. It details assets, liabilities, and shareholders' equity over multiple fiscal years, allowing users to analyze the company's financial health, liquidity, leverage, and return on equity. …
This article provides a valuation analysis of ABVC Biopharma Inc (ABVC), noting its current valuation score is 7.27, ranking 241 out of 386 in its industry. It highlights the company's P/E ratio of -2.56, but points out that key data for P/B, P/S, and …
This article provides details on the shareholder structure of ABVC Biopharma Inc (ABVC), outlining the major individual and corporate shareholders, as well as institutional holdings. It lists the proportion of shares held by key entities like Jiang (Shuling) and YuanGene, Corp, along with data …
This article presents the quarterly and annual income statements for ABVC Biopharma Inc (ABVC), offering detailed financial data on various metrics such as total revenue, operating expenses, and net income. It also includes an FAQ section explaining how to interpret the income statement and …
ABVC Biopharma Inc. (ABVC) is a clinical-stage biopharmaceutical company focused on developing therapies for various diseases, with its stock currently trading at $1.15, down 4.17%. Despite recent weak stock performance, the company's fundamentals are stable, and its growth potential is considered high. Analysts view …
Search by ticker symbol or company name and select a result to open its chart.